Bacterial proteases: current therapeutic use and future prospects for the development of new antibiotics

Bibliography

• Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (EDS.), Academic Press, London (1998):chapters 1–569.
   Google Scholar
• ••An excellent and comprehensive review on proteolyticenzymes.
   Google Scholar
• LEUNG D, ABBENANTE G, FAIRLIE DP: Protease inhibi- tors: current status and future prospects. J. Med. Chem. (2000) 43:305–341.
   PubMed Web of Science ®Google Scholar
• ••A very good review on the drug design and medicinal-chemical applications of protease inhibitors.
   Google Scholar
• WLODAWER A, GUSTCHINA A: Structural and biochemical studies of retroviral proteases. Biochim. Biophys. Acta (2000) 1 47 7 :16–34.
   Google Scholar
• ••An excellent paper on the HIV PR and their inhibitors,accounted by one of the most prominent figures in this research field (AW).
   Google Scholar
• FLEXNER C: Dual protease inhibitor therapy in HIV-infected patients: pharmacologic rationale and clinical benefits. Ann. Rev. Pharmacol. Toxicol. (2000) 40:649–674.
   PubMed Web of Science ®Google Scholar
• ••A very interesting review on the pharmacology and clinicalapplications of the five clinically approved HIV PR inhibitors.
   Google Scholar
• TRAVIS J, POTEMPA J: Bacterial proteinases as targets for the development of second generation antibiotics. Biochim. Biophys. Acta (2000) 1477:35–50.
   PubMed Web of Science ®Google Scholar
• •An interesting review on the Porphyromonas gingivalis and related proteases.
   Google Scholar
• MIYOSHI SI, SHINODA S: Bacterial metalloproteases as the toxic factor in infection. J. Toxicol Toxin Rev. (1997) 16:177–194.
   Web of Science ®Google Scholar
• MAEDA H: Role of microbial proteases in pathogenesis. Microbiol. Immunol (1996) 40:685–699.
   PubMed Web of Science ®Google Scholar
• RICE SA, GIVSKOV M, STEINBERG P, KJELLEBERG S: Bacterial signals and antagonists: the interaction between bacteria and higher organisms. J. MoL Microbiol. Biotechnol (1999) 1:23–31.
   PubMedGoogle Scholar
• WRIGHT GD: Resisting resistance: new strategies for battling superbugs. Chem. Biol. (2000) 7:R127–R132.
   Google Scholar
• RAWLINGS ND, BARRETT AJ: Evolutionary families of peptidases. Biochem. 1 (1993) 290:205–218.
   PubMed Web of Science ®Google Scholar
• BERGER A, SCHECHTER I: Mapping the active site of papain with the aid of peptide substrates and inhibi-tors. Philos. Trans. R. Soc. fond. [Biol.] (1970)257:249–264.
   PubMed Web of Science ®Google Scholar
• RAWLINGS ND: Introduction: Ser in e peptidases andtheir clans. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 1.
   Google Scholar
• SUPURAN CT, SCOZZAFAVA A, BRIGANTI F, CLARE BW:Protease inhibitors: synthesis and QSARstudy of novel classes of non-basic thrombin inhibitors incorpo-rating sulfonylguanidine and 0-methyl-sulfonyl-isour ea moieties at Pl. J. Med. Chem. (2000) 43:1793–1806.
   PubMedGoogle Scholar
• CLARE BW, SCOZZAFAVA A, BRIGANTI F, IORGA B, SUPURAN CT: Protease inhibitors. Part 2: weakly basic thrombin inhibitors incorporating sulfonylami-noguanidine moieties as Si anchoring groups - synthesis and structure-activity correlations. J Enz. Inhib. (2000) i5:235–264.
   Google Scholar
• SCOZZAFAVA A, BRIGANTI F, SUPURAN CT: Proteaseinhibitors. Part 3: synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilyl guanidine moieties at the P1 site. Eur. J Med. Chem. (1999) 34:939–952.
   Google Scholar
• SUPURAN CT, BRIGANTI F, SCOZZAFAVA A, ILIES MA:Protease inhibitors. Part 4: synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfan ilylam in o g-uan idin e moieties. J Enz. Inhib. (2000) 15:335–356.
   Google Scholar
• BARRETT AJ: Introduction: tissue kallikrein and its relatives. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr (Eds.), Academic Press, London (1998):chapter 28.
   Google Scholar
• JOHNSON DA: Tryptase. In: Handbook of Proteolytic Enzymes(CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 1.
   Google Scholar
• KIM IS, KANG SG, LEE KJ: Physiological importance of trypsin like protease during morphological differen-tiation of Streptomyces spp . J. MicrobioL (1995) 33:315–321.
   Web of Science ®Google Scholar
• YAMANE T, IWASAKI A, SUZUKI A, ASHIDA T, KAWATA Y:Crystal structure of Streptomyces erythraeus trypsin at 19 Ã resolution. J. Biochem. (Tokyo) (1995) 118:882–894.
   PubMed Web of Science ®Google Scholar
• BAARDSNES J, SIDHU S, MACLEOD A et al.: Streptomyces griseus protease B: secretion correlates with the length of the peptide. J Bacteriol (1998) 180:3241–3244.
   PubMed Web of Science ®Google Scholar
• QASIM MA: Streptogrisin B. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 77.
   Google Scholar
• LASKOWSKI M Jr, QASIM MA: What can the structure of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes ? Biochim. Biophys. Acta (2000) 1 477:324–337 .
   Google Scholar
• •A very interesting review on the proteinaceous serine protease inhibitors.
   Google Scholar
• SIDHU SS, BORGFORD TJ: Selection of Streptomyces griseusprotease B mutants with desired alterations in primary specificity using a library screening strategy. Mol. Biol (1996) 257:233–245.
   Web of Science ®Google Scholar
• ELLIOTT J, BENNET AJ, BRAUN CA, MACLEOD A, BORGFORD TJ: Active-site variants of Streptomyces griseus protease B with peptide-ligation activity. Chem. Biol. (2000) 7:163–171.
   Google Scholar
• DELBAERE LT, BRAYER GD: The 18 Ã structure of thecomplex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates. j Mol. Biol. (1985) 183:89–103.
   Google Scholar
• TOMKINSON NP, GALPIN IJ, BEYNON RJ: Syntheticanalogues of chymostatin. Inhibition of chymotrypsin and Streptomyces griseus proteinase A. Biochem. J. (1992) 286:475–480.
   Google Scholar
• BIRKTOFT JJ, BREDDAM K: Glutamyl endopeptidases. Methods Enzymol. (1994) 244:114–126.
   PubMed Web of Science ®Google Scholar
• STENNICKE HR, BREDDAM K: Glutamyl endopeptidase I. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 79.
   Google Scholar
• STENNICKE HR, BREDDAM K: Glutamyl endopeptidase II. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 80.
   Google Scholar
• HAMILTON R, WALKER B, WALKER BJ: Synthesis and proteinase inhibitory properties of diphenyl phsophonate analogues of aspartic and glutamic acids. Bioorg. Med. Chem. Lett. (1998) 8:1655–1660.
   PubMed Web of Science ®Google Scholar
• MELISH MF, GLASGOW LA, TURNER MD: The staphylo- coccal scalded-skin syndrome: isolation and partial characterization of the exfoliative toxin. J Infect. Dis. (1972) 125:129–140
   PubMed Web of Science ®Google Scholar
• LADHANI S, JOANNOU CL, LOCHRIE DP, EVANS RW, POSTON SM: Clinical, microbial and biochemical aspects of the exfoliative toxins causing staphylo-coccal scalded-skin syndrome. Clin. Microbiol Rev. (1999) 12:224–242.
   PubMed Web of Science ®Google Scholar
• PAPAGEORGIOU AC, PLANO LR, COLLINS CM, ACHARYA KR: Structural similarities and differences in Staphylo-coccus aureus exfoliative toxins A and B as revealed by their crystal structures. Protein Sci. (2000) 9:610–618.
   PubMed Web of Science ®Google Scholar
• RADER SD, AGARD DA: a-Lytic protease. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 82.
   Google Scholar
• DAVIS JH, AGARD DA: Relationship between enzyme specificity and the backbone dynamics of free and inhibited a-lytic protease. Biochemistry (1998) 37:7696–7707.
   PubMed Web of Science ®Google Scholar
• FUJINAGA M, DELBAERE LT, BRAYER GD, JAMES MN: Refined structure of a-lytic protease at 17 Äresolution. Analysis of hydrogen bonding and solvent structure./ Mol. Biol. (1985) 184:479–502.
   Google Scholar
• LI S, NORIOKA S, SAKIYAMA F: Purification, staphylo-lytic activity and cleavage sites of a-lytic protease from Achromobacter lyticus. J. Biochem. (Tokyo) (1997) 122:772–778.
   PubMed Web of Science ®Google Scholar
• PALLEN MJ, WREN BW: The HtrA family of serine proteases. Mol. Microbiol. (1997) 26:209–221.
   PubMed Web of Science ®Google Scholar
• SPIESS C, BEIL A, EHRMANN M: A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell (1999) 97:339–347.
   PubMed Web of Science ®Google Scholar
• LASKOWSKA E, KUCZYNSKA-WISNIK D, SKORKO-GLONEK J, TYLOR A: Degradation by pro teases Inn, Clp and HtrA, of Escherichia coli proteins aggregated in vivoby heat shock; HtrA protease action in vivoand in vitro. Mol. Microbiol. (1997) 22:555–571
   Web of Science ®Google Scholar
• KOLMAR H: DegP or protease Do. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 83.
   Google Scholar
• SAKIYAMA F, MASAKI T: Lysyl endopeptidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 85.
   Google Scholar
• LI S, NORIOKA S, MASAKI T: Bacteriolytic activity and specificity of Achromobacter beta-lytic protease. J Biochem. (Tokyo) (1998) 124:332–339.
   PubMed Web of Science ®Google Scholar
• POULSEN K, REINHOLDT J, JESPERSGAARD C et al.: A comprehensive genetic study of strptococcal immuno-globulin Al proteases: evidence for recombination within and between species. Infect. Immun. (1998) 66:181–190.
   PubMed Web of Science ®Google Scholar
• POULSEN K, KILIAN M: IgAl -specific serine endopepti-dase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 87.
   Google Scholar
• LORENZEN DR, DUX F, WOLK U, TSIRPOUCHTSIDIS A, HAAS G, MEYER TF: Irnmunoglobulin Al protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. J Exp. Med. (1999) 190:1049–1058.
   PubMed Web of Science ®Google Scholar
• CUNNINGHAM MW: Pathogenesis of group A strepto-coccal infections. Clin. Microbiol. Rev. (2000) 13:470–511.
   PubMed Web of Science ®Google Scholar
• EFSTRATIOU A: Group A streptococci in the 1990s. Antimicrob. Chemother. (2000) 45 (Suppl):3–12.
   Google Scholar
• JI Y, SCHNITZLER N, DEMASTER E, CLEARY P: Impact of M49, Mrp, Enn and C5a peptidase proteins on coloni-zation of the mouse oral mucosa by Streptococcus pyogenes. Infect. Immun. (1998) 66:5399–5405.
   PubMed Web of Science ®Google Scholar
• STAFSLIEN DK, CLEARY PP: Characterization of thestreptococcal C5a peptidase using a C5a-green fluores-cent fusion protein substrate. J. Bacteriol. (2000) 182:3254–3258.
   PubMed Web of Science ®Google Scholar
• KORTT AA, STEWART DJ: Dichelobacter (sheep foot-rot) basic serine proteinase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 101.
   Google Scholar
• KORTT AA, STEWART DJ: Properties of the ex tracellularacidic proteases of Dichelobacter nodosus. Stability and specificity of peptide bond cleavage. Biochem. Mol. Biol. Int. (1994) 34:1167–1176.
   PubMedGoogle Scholar
• KORTT AA, BURNS JE, VAUGHAN JA, STEWART DJ: Purifi-cation of the ex tracellular acidic proteases of Dichelo-bacter nodosus. Biochem. Mol. Biol. Int. (1994)34:1157–1166.
   PubMedGoogle Scholar
• LIU D, YONG WK: Improved laboratory diagnosis of ovine footrot: an update. Vet. J (1997) 153:99–105.
   PubMed Web of Science ®Google Scholar
• ISHIHARA K, OKUDA K: Molecular pathogenesis of the cell surface proteins and lipids from Treponema denticola. FEMS Microbiol. Lett. (1999) 181:199–204.
   PubMed Web of Science ®Google Scholar
• ROSEN G, NAOR R, SELA MN: Multiple forms of the major phenylalanine specific protease in Treponema denticola. J. Periodontal. Res. (1999) 34:269–276.
   PubMed Web of Science ®Google Scholar
• UITTO VJ: Tr epolisin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 102.
   Google Scholar
• SUPURAN CT, SCOZZAFAVA A: Matrix metalloprote-inases (MMPs). In: Proteinase and peptidase inhibition: Recent potential targets for drug development. Smith HJ, Simons C (Eds.), Harwood Academic Press, London 2001 (in press).
   Google Scholar
• BUTLER MJ: Tripeptidyl-peptidases A, B and C. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 140.
   Google Scholar
• BANBULA A, MAK P, BUGNO M et al: Pr olyl tripeptidyl peptidase from Porphyromonas gingivalis: a novel enzyme with possible pathological implications for the development of periodontitis. J Biol. Chem. (1999) 274:9246–9252.
   PubMed Web of Science ®Google Scholar
• KITAZONO A, KABASHIMA T, HUANG HS, ITO K, YOSHIMOTO T: Prolyl aminopeptidase gene from Flavobacterium meningosepticum: cloning, purifica-tion of the expressed enzyme and analysis of its sequence. Arch. Biochem. Biophys. (1996) 3 36:35–41.
   Google Scholar
• FEDORKO DP, WILLIAMS EC: Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile.J. Clin. Microbiol. (1997) 35:1258–1259.
   PubMed Web of Science ®Google Scholar
• YOSHIMOTO T, KABASHIMA T, UCHIKAWA K et al.: Crystal structure of prolyl aminopeptidase from Serratia marcescens. J. Biochem. (Tokyo) (1999) 126:559–565.
   PubMed Web of Science ®Google Scholar
• MEDRANO FJ, ALONSO J, GARCIA JL, ROMERO A, BODE W, GOMIS-RUTH FX: Structure of proline iminopepti-dase from Xanthomonas campestris pv. citri: a prototype for the prolyl oligopeptidase family. EMBOJ (1998) 17:1–9.
   Google Scholar
• GHUYSEN JM: Str ep to my ce s K15 D-Ala-D-Ala tr an sp ep - tidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 144.
   Google Scholar
• GRANDCHAMPS J, NGUYEN-DISTECHE M, DAMBLON C, FRERE JM, GHUYSEN JM: Streptomyces K15 active-site serine DD-transpeptidase: specificity profile for © Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (2001) 11(2) peptide, thiol ester and ester carbonyl donors and pathways of the transfer reactions. Biochem. J (1995) 307:335–339.
   Google Scholar
• FONZE E, VERMEIRE M, NGUYEN-DISTECHE M, BRASSEUR R, CHARLIER P: The crystal structure of a penicilloyl-serine transferase of intermediate penicillin sensitivity. The DD-transpeptidase of streptomyces K15 .j Biol. Chem. (1999) 274:21853–21860.
   Google Scholar
• FRERE JM: Streptomyces R61 D-Ala-D-Ala carboxyp ep ti-dase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 145.
   Google Scholar
• ADEDIRAN SA, PRATT RF: Beta-secondary and solvent deuterium kinetic isotope effects on catalysis by the Streptomyces R61 DD-peptidase: comparisons with a structurally similar class C beta-lactamase. Biochem-istry (1999) 38:1469–1477.
   PubMed Web of Science ®Google Scholar
• CABARET D, LIU J, WAKSELMAN M, PRATT RF, XU Y: Functionalized depsipeptides, substrates and inhibi-tors of beta-lactamases and DD-p ep tidases. Bioorg. Med. Chem. (1994) 2:757–771.
   PubMedGoogle Scholar
• DALBEY RE: Signal peptidase I. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 153.
   Google Scholar
• STEIN RL, BARBOSA MD, BRUCKNER R: Kinetic and mechanistic studies of signal peptidase I from Escheri-chia coil Biochemistry (2000) 39:7973–7983.
   Google Scholar
• ALLSOP AE, BROOKS G, BRUTON G et al.: Penem inhibi-tors of bacterial signal peptidase. Bioorg. Med. Chem. Lett. (1995) 5:443–448.
   Web of Science ®Google Scholar
• STATHOPOULOS C: Structural features, physiological roles and biotechnological applications of the membrane proteases of the OmpT bacterial endopep-tidase family: a micro-review. Membr. Cell Biol. (1998) 12:1–8.
   PubMedGoogle Scholar
• KRAMER RA, DEKKER N, EGMOND MR: Identification ofactive site serine and histidine residues in Escherichia coli outer membrane protease OmpT. FEBS LetL (2000) 468:220–224.
   PubMed Web of Science ®Google Scholar
• KRAMER RA, ZANDWIJKEN D, EGMOND MR, DEKKER N: In vitro folding, purification and characterization of Escherichia coliouter membrane protease ompT. Eur. Biochem. (2000) 267:885–893.
   PubMedGoogle Scholar
• MAURIZI MR: Endopeptidase Op. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 177.
   Google Scholar
• HERMAN C, D'ART R: Proteolysis and chaperones: the destruction /reconstruction dilemma. CUIT. Opin. Microbic)]. (1998) 1:204–209.
   PubMed Web of Science ®Google Scholar
• OTTO HH, SCHIRMEISTER T: Cysteine proteases and their inhibitors. Chem. Rev. (1997) 97:133–171.
   PubMed Web of Science ®Google Scholar
• ••An excellent review of this family of enzymes and of theirmain types of inhibitors.
   Google Scholar
• WATTS AB, BROCKLEHURST K: Streptopain. In:Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 221.
   Google Scholar
• HERWALD H, COLLIN M, MULLER-ESTERL W, BJORCK L:Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J. Exp. Merl. (1996) 184:665–673.
   PubMed Web of Science ®Google Scholar
• SUGAWARA S, NEMOTO E, TADA H, MIYAKE K, IMAMURA T, TAKADA H: Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopoly-saccharide hyporesponsiveness. j Immunol (2000) 165:411–418.
   PubMed Web of Science ®Google Scholar
• ULMANN D, BORDUSA F: aostripain. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 257.
   Google Scholar
• CHEN JM, RAWLINGS ND, STEVENS RA, BARRETT AJ: Identification of the active site of leg-umain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases. FEBS Lett. (1998) 441:361–365.
   PubMed Web of Science ®Google Scholar
• SCHIRMEISTER T, PERIC M: Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carbox-ylic acid function on inhibition. Bioorg. Merl. Chem. (2000) 8:1281–1291.
   PubMed Web of Science ®Google Scholar
• GUNTHER R, STEIN A, BORDUSA F: Investigations on the enzyme specificity of clostripain: a new efficient biocatalyst for the synthesis of p eptide isosteres. j. Org. Chem. (2000) 65:1672–1679.
   PubMed Web of Science ®Google Scholar
• •An interesting paper on the applications of clostripain in peptide/peptide isosteres synthesis.
   Google Scholar
• BORDUSA F: Nonconventional amide bond formation catalysis: programming enzyme specificity with substrate mimetics. Braz. J. Merl. Biol. Res. (2000) 33:469–485.
   PubMed Web of Science ®Google Scholar
• ••An excellent review on the use of proteases as catalysts forpeptide synthesis.
   Google Scholar
• CUMMINS PM, O'CONNOR B: Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim. Biophys. Acta (1998) 1429:1–17.
   PubMedGoogle Scholar
• •An interesting review of the pyroglutamyl peptidases.
   Google Scholar
• AWADE A, CLEUZIAT P, GONZALES T, ROBERT-BAUDOUY J: Pyrrolidone carboxyl peptidase (Pcp): an enzyme that removes pyroglutamic acid (pG1u) from p Glu-p ep tide s and p Glu-proteins. Proteins Struct. Funct. Genet. (1994) 20:34–51.
   PubMed Web of Science ®Google Scholar
• BUNDGAARD H, MOSS J: Prodrugs of peptides. W.Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminoethylation to effect protection against pyroglutamyl aminopeptidase. Pharm. Sci. (1989) 78:122–126.
   Google Scholar
• CHEUNG HTA, DONG Z, ESCOFFER L, SMAL MA, TATTER-SALL MHN: Activation by peptidases and cytotoxicity of 2-(L-a-aminoacyl) prodrugs of methotrexate. In: Chemistry, and Biology of Pteridines and Folates. Ayling, JE, Nair MG, Baugh CM (Eds.), Plenum Press, New York (1993)457–460.
   Google Scholar
• GENCO CA, POTEMPA J, MIKOLAJCZYK-PAWLINSKA J, TRAVIS J: Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin. Infect. Dis. (1999) 28:456–465.
   PubMed Web of Science ®Google Scholar
• GRAVES D, JIANG Y, GENCO CA: Periodontal disease:bacterial virulence factors, host response and impact on systemic health. Curr. Opin. Infect. Dis. (2000) 13:227–232.
   PubMed Web of Science ®Google Scholar
• POTEMPA J, TRAVIS J: Gingipain Rand gingipains K. In:Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 258.
   Google Scholar
• SHI Y, RATNAYAKE DB, OKAMOTO K, ABE N, YAMAMOTO K, NAKAYAMA K: Genetic analyses of proteolysis, hemoglobin binding and hemagglutina-tion of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp and hagA. J. Biol. Chem. (1999) 274:17955–17960.
   Google Scholar
• GENCO CA, ODUSANYA BM, POTEMPA J, MIKOLAJCZYK-PAWLINSKA J, TRAVIS J: A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect. Immun. (1998) 66:4108–4114.
   PubMed Web of Science ®Google Scholar
• EICHINGER A, BEISEL HG, JACOB U et al.: Crystal structure of gingipain R an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBOJ. (1999)18:5453–5462.
   PubMed Web of Science ®Google Scholar
• ••The first report of the 3-dimensional structure of gingipain R(free and inhibited with a chloroketone derivative). This work is of considerable interest for the design of specific and potent inhibitors for these enzymes involved in serious pathologies.
   Google Scholar
• POTEMPA J, PIKER, TRAVIS J: Titration and mapping of the active site of cysteine proteinases from Porphyro-monas gingivalis (gin gip ain s) using pep tidyl ch lo r o - m e th an es. Biol. Chem. (1997) 378:223–230.
   PubMed Web of Science ®Google Scholar
• JONES CH, HRUBY DE: New targets for antibiotic development: biogenesis of surface adherence structures. Drug Dev. Today (1998) 3:495–504.
   Web of Science ®Google Scholar
• MAZMANIAN SK, LIU G, TON-THAT H, SCHNEEWIND 0: Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science (1999) 285:760–763
   PubMed Web of Science ®Google Scholar
• ••A seminal paper in which bacterial strains defective insortase are described, together with the mechanism by which this protease anchors surface proteins to the cell wall.
   Google Scholar
• TON-THAT H, LIU G, MAZMANIAN SK, FAULL KF, SCHNEEWIND 0: Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus, at the LPXTG motif. Proc. Natl. Acad. Sci. USA (1999) 96:12424–12429.
   PubMed Web of Science ®Google Scholar
• TON-THAT H, SCHNEEWIND 0: Anchor structure of staphylococcal surface proteins. IV. Inhibitors of the cell wall sorting. J. Biol. Chem. (1999) 274:24316–24320.
   Google Scholar
• ••A paper in which the first sortase inhibitors are described.
   Google Scholar
• TON-THAT H, MAZMANIAN SK, FAULL KF, SCHNEEWIND 0: Anchoring of surface proteins to the cell wall of Staphylococcus aureus. J. Biol. Chem. (2000)275:9876–9881.
   PubMed Web of Science ®Google Scholar
• COSSART P, JONQUIERES R: Sortase, a universal target for therapeutic agents against Gram-positive bacteria? Proc. Natl. Acad. Sci. USA (2000) 97:5013–5015.
   PubMed Web of Science ®Google Scholar
• MAZMANIAN SK, LIU G, LENOY E, SCHNEEWIND 0: Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infection. Proc. Natl. Acad. Sci. USA (2000) 97:5510–5515.
   PubMed Web of Science ®Google Scholar
• ••In this paper it is clearly proven that bacteria expressingmutant sortase are non-pathogenic and cannot infect their host animals.
   Google Scholar
• NAVARRE WW, SCHNEEWIND 0: Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbic)]. Mol. Biol. Rev. (1999) 63:174–229.
   PubMed Web of Science ®Google Scholar
• ••An excellent and exhaustive review on the mechanisms oftargeting of surface proteins of Gram-positive bacteria.
   Google Scholar
• COLEMAN JE: Zinc enzymes. Curr. Opin. Chem. Biol. (1998) 2:222–234.
   PubMed Web of Science ®Google Scholar
• •An interesting review on zinc enzymes, including some zinc proteases.
   Google Scholar
• SHINODA S, MIYOSHI SI, WAKAE H, RAHMAN M, TOMOCHIKA KI: Bacterial proteases as pathogenic factors, with special emphasis on vibrio proteases. Toxicol. Toxin Rev. (1996) 15:327–339.
   Web of Science ®Google Scholar
• VOLLMER P, WALEV I, ROSE-JOHN S, BHAKDI S: Novel pathogenic mechanism of microbial metalloprote-inase:Liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. 11711711117. (1996) 64:3646-3651.
   Google Scholar
• SCHIAVO G, MATTEOLI M, MONTECUCCO C: Neurotoxins affecting neuroexocytosis. Physic)]. Rev. (2000) 80:717–766.
   PubMed Web of Science ®Google Scholar
• ••An exhaustive and excellent review on the Clostridianeurotoxins, by the discoverers of the metalloprotease nature of these toxins.
   Google Scholar
• HUMEAU Y, DOUSSAU F, GRANT NJ, POULAIN B: How botulinum and tetanus neurotoxins block neurotrans-mitter release. Biochimie (2000) 82:427–446.
   PubMed Web of Science ®Google Scholar
• ••An excellent review on the biochemical mechanismsconnected with the blocking of neurotransmitter release by the botulinum/tetanus MPRs.
   Google Scholar
• BEYNON RJ, BEAUMONT A: Thermolysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 351.
   Google Scholar
• MARQUIS H, HAGER EJ: pH-regulated activation and release of a bacteria-associated phospholipase C during intracellular infection by Listeria monocyto-genes. Mol. Microbic)]. (2000) 35:289–298.
   PubMed Web of Science ®Google Scholar
• COFFEY A, VAN DEN BURG B, VELTMAN R, ABEE T: Characteristics of the biologically active 35-kDa metalloprotease virulence factor from Listeria monocytogenes. j Appl. Mkrobiol. (2000) 88:132–141.
   Google Scholar
• MAKINEN PL, MAKINEN KK: The Enterococcus faecalis ex tracellular metalloendopeptidase (EC 342430; coccolysin) inactivates human endothelin at bonds involving hydrophobic amino acid residues. Biochem. Biophys. Res. Commun. (1994) 200:981–985.
   PubMed Web of Science ®Google Scholar
• NAGAMUNE K, YAMAMOTO K, NAKA A, MATSUYAMA J, MIWATANI T, HONDA T: In vitrop roteoly tic processing and activation of the recombinant precursor of El Tor cyto ly sin A em o ly sin (pro-HlyA) of Vibrio cholerae by soluble hemagglutinin /pr o tease of V. cholerae, trypsin and other proteases. Infect. Immun. (1996) 64:4655–4658.
   PubMed Web of Science ®Google Scholar
• BENITEZ JA, GARCIA L, SILVA A et al.: Preliminary assess-ment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin /protease-defective El Tor strain as a cholera vaccine candidate. Infect. Immun. (1999) 67:539–545.
   PubMed Web of Science ®Google Scholar
• KON Y, TSUKADA H, HASEGAWA T et al: The role of Pseudomonas aeruginosa elastase as a potent inflam-matory factor in a rat air pouch inflammation model. FEMS Immunol. Med. Microbiol (1999) 25:313–321.
   PubMedGoogle Scholar
• PESCI EC, MILBANK JB, PEARSON JP et al.: Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA (1999) 96:11229–11234.
   PubMed Web of Science ®Google Scholar
• KESSLER E, OHMAN DE: Pseudolysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 357.
   Google Scholar
• WOESSNER JF: Izgionella metalloendopeptidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 358.
   Google Scholar
• MOFFAT JF, EDELSTEIN PH, REGULA DP, CIRILLO JD, TOMPKINS LS: Effects of an isogenic Zn- metalloprote-ase- deficient mutant of Izgionella pneumophila in a guinea-pig pneumonia model. Mol. Mkrobiol. (1994) 12:693–705.
   Google Scholar
• JUNG CM, MATSUSHITA 0, KATAYAMA S, MINAMI J, SAKURAI J, OKABE A: Identification of metal ligands in the Clostridium histolyticum ColH collagen ase. J. Bacteriol. (1999) 1 81:2816–2822.
   Google Scholar
• •An interesting paper, reporting the identification of the zinc ligands of ChC.
   Google Scholar
• MATSUSHITA 0, JUNG CM, MINAMI J, KATAYAMA S, NISHI N, OKABE A: A study of the collagen-binding domain of a 116 -kDa Clostridium histolyticum collage-nase. j Biol. Chem. (1998) 273:3643–3648.
   PubMed Web of Science ®Google Scholar
• FUKUSHIMA J, OKUDA K: Vibrio collagenase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 367.
   Google Scholar
• VAN WART HE: Clostridium collagenase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 368.
   Google Scholar
• BOND MD, VAN WART HE: Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography. Biochemistry (1984) 23:3077–3085.
   PubMed Web of Science ®Google Scholar
• BOND MD, VAN WART HE: Characterization of the individual collagenases from Clostridium histolyticum. Biochemistry (1984) 23:3085–3091.
   PubMed Web of Science ®Google Scholar
• JUNG W, WINTER H: Considerations for the use of clostridial collagenase in clinical practice. Chn. Drug Invest. (1998) 15:245–252.
   Web of Science ®Google Scholar
• SCOZZAFAVA A, SUPURAN CT: Protease inhibitors: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties. J. Med. Chem. (2000) 43:1858–1865.
   PubMed Web of Science ®Google Scholar
• VALEE BL, AULD DS: Zinc coordination, function and structure of zinc enzymes and other proteins. Biochem-istry (1990) 29:5647–5659.
   PubMed Web of Science ®Google Scholar
• LARSEN KS, ZHANG K, AULD DS: D-Phe complexes of zinc and cobalt carboxypeptidase A. J Inorg. Biochem. (1996) 64:149–162.
   PubMed Web of Science ®Google Scholar
• SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase and matrix metalloproteinase inhibitors. Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of carbonic anhydrase isozymes I, II and IV and N-hydroxysulfonamides inhibit both these zinc enzymes. J. Med. Chem. (2000) 43:3677–3687.
   Google Scholar
• SCOZZAFAVA A, SUPURAN CT: Protease inhibitors. Part 5 alkyl/arylsulfonyl- and arylsulfonylureido-/ arylureido-glycine hydroxamate inhibitors of Clostridium histolyticum collagenase. Eur. J. Med. Chem. (2000) 35:299–307.
   Google Scholar
• SUPURAN CT, BRIGANTI F, MINCIONE G, SCOZZAFAVA A: Protease inhibitors: synthesis of L-alanine hydroxa-mate sulfonylated derivatives as inhibitors of Clostridium histolyticum collagenase. J. Enz. Inhib. (2000) 15:111–128.
   Google Scholar
• SUPURAN CT, SCOZZAFAVA A: Protease inhibitors. Part7: inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate. Eur. j Pharm. Sci. (2000) 10:67–76.
   Google Scholar
• SCOZZAFAVA A, SUPURAN CT: Protease inhibitors. Part8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alan in e hydroxamate moieties. Bioorg. Med. Chem. (2000) 8:637–645.
   Google Scholar
• SCOZZAFAVA A, SUPURAN CT: Protease inhibitors. Part9: synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl-Lralanine hydroxa-mate moieties. Bioorg. Med. Chem. Lett. (2000) 1 0 :499–502.
   Google Scholar
• SCOZZAFAVA A, ILIES MA, MANOLE G, SUPURAN CT: Protease inhibitors. Part 12: synthesis of potent matrix metalloproteinase and bacterial collagenase inhibi-tors incorporating sulfonylated N-4-nitrobenzy1-13-alanine hydroxamate moieties. Eur. j Pharm. Sci. (2000) 11:69–79.
   Google Scholar
• SCHIFF WM, SPEAKER MG, MCCORMICK SA: The collagen shield as a collagenase inhibitor and clinical indicator of collagenase activity on the ocular surface. CLAO J. (1992) 18:59–63.
   PubMedGoogle Scholar
• CLINCH TE, HOBDEN JA, HILL JM, O'CALLAGHAN RJ, ENGEL LS, KAUFMANN HE: Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis. CLAO j (1992) 18:245–247.
   PubMedGoogle Scholar
• KUWANO M, HORIBE Y, KAWASHIMA Y: Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J. Ocul Pharmacol. Ther. (1997) 13:31–40
   PubMed Web of Science ®Google Scholar
• HARDING KG, BALE S, LLEWELLYN M, BAGGOT J, ROBBINS K: A pilot study of Clostridium collagenase (Collagenase ABC(')) ointment in the debridement of dermal ulcers. Clin. Drug Invest. (1996) 11:139–144.
   Web of Science ®Google Scholar
• JUNG W, WINTER H: Considerations for the use of Clostridial collagenase in clinical practice. Clin. Drug Invest. (1998) 15:245–252.
   Web of Science ®Google Scholar
• •An interesting review on the clinical use of bacterial collagenases.
   Google Scholar
• LUND T, GRANUM PE:. The 105-kDa protein component of Bacillus cereus non-hemolytic enterotoxin is a metalloprotease with gelatinolytic and collagenolytic activity. FEMS Microbiol. Lett. (1999) 178:355–361.
   Google Scholar
• LOUIS D, BERNILLON J, PAISSE JO, WALLACH JM: Use of liquid chromatography-mass spectrometry coupling for monitoring the serralysin-catalyzed hydrolysis of a peptide library. J. Chromatogr. B. Biomed. Sci. Appl. (1999) 732:271–276.
   PubMed Web of Science ®Google Scholar
• BAUMANN U: Serralysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 386.
   Google Scholar
• MORIHARA K: Aeruginolysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 387.
   Google Scholar
• BELAS R: Mirabilysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 388.
   Google Scholar
• FRANCO AA, CHENG RK, CHUNG GT, WU S, OH HB, SEARS CL: Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. Bacteriol. (1999) 181:6623–6633.
   PubMed Web of Science ®Google Scholar
• OBISO RJ, BEVAN DR, WILKINS TD: Molecular modeling and analysis of the Bacteroides fragilis toxin. Clin. Infect. Dis. (1997) 25 (Suppl. 2):5153–5155.
   Google Scholar
• MONCRIEF JS, DUNCAN AJ, WRIGHT RL, BARROSO LA, WILKINS TD: Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect. Immun. (1998) 66:1735–1739.
   PubMed Web of Science ®Google Scholar
• MONCRIEF JS, OBISO R JR, BARROSO LA et al.: The enterotoxin of Bacteroides fragilis is a metallopro-tease. Infect. Immun. (1995) 63:175–181.
   PubMed Web of Science ®Google Scholar
• TEPLYAKOV A, POLYAKOV K, OBMOLOVA G et al: Crystal structure of carboxypeptidase T from Thermoactinomyces vulgaris. Eur. J. Biochem. (1992) 208:281–288.
   PubMedGoogle Scholar
• STRATER N, SHERRATT DJ, COLLOMS SD: X-ray structure of aminopeptidase A from Escherichia coil and a model for the nucleoprotein complex in Xer site-specific recombination. EMBO J. (1999) 18:4513–4522.
   PubMed Web of Science ®Google Scholar
• STRATER N, SUN L, KANTROWITZ ER, LIPSCOMB WN: A bicarbonate ion as a general base in the mechanism of peptide hydrolysis by dizinc leucine aminopeptidase. Proc. Natl. Acad. Sci. USA (1999) 96:11151–11155.
   PubMed Web of Science ®Google Scholar
• MATHEW Z, KNOX TM, MILLER CG: Salmonella enterica serovar typhimurium peptidase B is a leucyl aminopeptidase with specificity for acidic amino acids. J. Bacteriol. (2000) 182:3383–3393.
   PubMed Web of Science ®Google Scholar
• MAHADEVAN D, SALDANHA JW: The ex tracellular regions of PSMA and the transferrin receptor contain an aminopeptidase domain: implications for drug design. Protein Sci. (1999) 8:2546–2549.
   PubMed Web of Science ®Google Scholar
• HUNTINGTON KM, BIENVENUE DL, WEI Y, BENNETT B, HOLZ RC, PEI D: Slow-binding inhibition of the aminopeptidase from Aeromonas proteolytica by peptide thiols: synthesis and spectroscopic characteri-zation. Biochemistry (1999) 38:15587–15596.
   PubMed Web of Science ®Google Scholar
• LOWTHER WT, MATTHEWS BW: Structure and function of the methionine aminopeptidases. Biochim. Biophys. Acta (2000) 1477:157–167.
   PubMed Web of Science ®Google Scholar
• •An interesting review article.
   Google Scholar
• ARFIN SM, KENDALL RL, HALL L et al.: Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc. Natl. Acad. Sci. USA (1995) 92:7714–7718.
   PubMed Web of Science ®Google Scholar
• LI X, CHANG YH Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopepti-dases. Proc. Natl. Acad. Sci. USA (1995) 92:12357–12361.
   PubMed Web of Science ®Google Scholar
• RODERICK SL, MATTHEWS BW Structure of the cobalt-dependent methionine aminopeptidase from Escheri-chia coli: a new type of proteolytic enzyme. Biochem-istry (1993) 32:3907–3912.
   PubMed Web of Science ®Google Scholar
• WILCE MCJ, BOND CS, DIXON NE et al.: Structure and mechanism of proline-specific aminopeptidase from Escherichia coil Proc. Natl. Acad. Sci. USA (1998) 95:3472–3477.
   PubMed Web of Science ®Google Scholar
• SHERWOOD RF, MELTON RG: Glutamate carboxyp epti-dase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 483.
   Google Scholar
• GALIVAN J, RYAN TJ, CHAVE K, RHEE M, YAO R, YIN D: Glutamyl hydrolase: pharmacological role and enzymatic characterization. Pharmacol. Ther. (2000) 85:207–215.
   PubMed Web of Science ®Google Scholar
• ROWSELL S, PAUPTIT RA, TUCKER AD, MELTON RG, BLOW DM, BRICK P Crystal structure of carboxyp epti-dase G2, a bacterial enzyme with applications in cancer therapy. Structure (1997) 5:337–347.
   PubMed Web of Science ®Google Scholar
• MELTON RG, SHERWOOD RF: Antibody-enzyme conjugates for cancer therapy. J. Natl. CancerInst (1996) 88:153–165.
   PubMed Web of Science ®Google Scholar
• LESSARD IA, WALSH CT: VanX, a bacterial D-alanyl-D-alanine dip eptidase: resistance, immunity, or survival function? Proc. Nati Acad Sci. USA (1999) 96:11028–11032.
   PubMed Web of Science ®Google Scholar
• MCCAFFERTY DG, LESSARD IA, WALSH CT: Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX. Biochemistry (1997) 36:10498–10505.
   PubMed Web of Science ®Google Scholar
• WU Z, WALSH CT: Dithiol compounds: potent, time-dependent inhibitors of VanX, a zinc-dependent D,D-dipeptidase required for vancomycin resistance in Enterococcus faecium. J. Am. Chem. Soc. (1996) 118:1785–1786.
   Web of Science ®Google Scholar
• BUSSIERE DE, PRATT SD, KATZ L, SEVERIN JM, HOLZMAN T, PARK C: The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol. Cell (1998) 2:75–84.
   PubMed Web of Science ®Google Scholar
• MELLORS A: 0-Sialoglycoprotein en dop ep tidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 505.
   Google Scholar
• KESSLER E:13-Lytic metalloendopeptidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 506.
   Google Scholar
• KESSLER E, OHMAN DE : Staphylolysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 507.
   Google Scholar
• RYDING U, RENNEBERG J, ROLLOF J, CHRISTENSSON B: Antibody response to Staphylococcus aureus whole cell, lipase and staphylolysin in patients with S. aureus infections. FEMS Microbiol. Immunol. (1992) 4:105–110.
   PubMedGoogle Scholar
• PLAUT AG: IgA-specific metalloendopeptidase. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 508.
   Google Scholar
• POULSEN K, REINHOLDT J, JESPERSGAARD C et al.: A comprehensive genetic study of streptococcal immunoglobulin Al proteases: evidence for recombi-nation within and between species. Infect. Immun. (1998) 66:181–190.
   PubMed Web of Science ®Google Scholar
• SCHIAVO G, BENFENATI F, POULAIN B et al.: Tetanus and botulinum-B neurotoxinsblock neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature (1992) 359:832–834.
   PubMed Web of Science ®Google Scholar
• ••This paper shows that the neurotoxins provoking tetanusand botulism are zinc endoproteases.
   Google Scholar
• SCHIAVO G, ROSSETTO 0, CATSICAS S et al.: Identifica-tion of the nerve terminal targets of botulinum neurotoxins serotypes A, D and El Biol. Chem. (1993) 268:23784–23787.
   Google Scholar
• LACY DB, TEPP W, COHEN AC, DASGUPTA BR, STEVENS RC: Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nature Struct. Biol. (1998) 5:898–902.
   PubMedGoogle Scholar
• ••This paper reports the first x-ray crystallographic structure ofa neurotoxins of the protease type.
   Google Scholar
• MARTIN L, CORNILLE F, CORIC P, ROQUES BP, FOURNIÉ-ZALUSKI MC: I3-Amino-thiols inhibit the zinc metallopeptidase activity of tetanus toxin light chain. J. Med. Chem. (1998) 41:3450–3460.
   PubMed Web of Science ®Google Scholar
• ••The first potent inhibitors of TeNT reported.
   Google Scholar
• SUPURAN CT, SCOZZAFAVA A: Carbonic anhydrase inhibitors and their therapeutic potential. Exp. Opin. Ther. Patents (2000) 10:575–600.
   Web of Science ®Google Scholar
• ••An exhaustive review on the carbonic anhydrase inhibitors.
   Google Scholar
• SCOZZAFAVA A, MENABUONI L, MINCIONE F, BRIGANTI F, MINCIONE G, SUPURAN CT: Carbonic anhydrase inhibitors: Synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J. Med. Chem. (1999) 42:2641–2650.
   Web of Science ®Google Scholar
• SCOTT AB: Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology (1980) 87:1044–1049.
   PubMed Web of Science ®Google Scholar
• HUANG W, FOSTER JA, ROGACHEFSKY AS: Pharma-cology of botulinum toxin. j Am. Acad. Dermatol. (2000) 43:249–259.
   PubMed Web of Science ®Google Scholar
• SOLOMON BA, HAYMAN R: Botulinum toxin type A for palmar and digital hyperhidrosis. J. Am. Acad. Dermatol. (2000) 42:1026–1029.
   PubMed Web of Science ®Google Scholar
• ELLIOTT JL, MOGRIDGE J, COLLIER RJ: A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry (2000) 39:6706–6713.
   PubMed Web of Science ®Google Scholar
• LEPPLA SH: Anthrax toxin lethal factor. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 511.
   Google Scholar
• DUESBERY NS, WEBB CP, LEPPLA SH et al.: Proteolytic inactivation of MAP-kin ase-kin ase by anthrax lethal factor. Science (1998) 280:734–737.
   PubMed Web of Science ®Google Scholar
• VITALE G, PELLIZZARI R, RECCHI C, NAPOLITANI G, MOCK M, MONTECUCCO C: Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. (1998) 248:706–711.
   PubMed Web of Science ®Google Scholar
• PELLIZZARI R, GUIDI-RONTANI C, VITALE G, MOCK M, MONTECUCCO C: Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFN-7-induced release of NO and TNF-a. FEBS Lett. (1999) 462:199–204.
   PubMed Web of Science ®Google Scholar
• MENARD A, PAPINI E, MOCK M, MONTECUCCO C: The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors. Biochem. 1 (1996) 320:687-691.© Ashley Publications Ltd. All rights reserved.Exp. Opin. Ther. Patents (2001) 11(2)
   Google Scholar
• PARK PW, MECHAM RP: Lysostaphin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998):chapter 515.
   Google Scholar
• BANBULA A, POTEMPA J, TRAVIS J et al: Amino acid sequence and three-dimensional structure of the Staphylococcus aureus metalloproteinase at 1.72 Ã resolution. Structure (1998) 6:1185–1193.
   PubMed Web of Science ®Google Scholar
• POTEMPA J, DUBIN A, TRAVIS J: Aureolysin. In: Handbook of Proteolytic Enzymes (CD-ROM). Barrett AJ, Rawlings ND, Woessner, JF Jr. (Eds.), Academic Press, London (1998) chapter 538.
   Google Scholar
• LANGER T: AAA proteases: cellular machines for degradingmembrane proteins. TIBS (2000) 25:247–251.
   PubMed Web of Science ®Google Scholar
• SCHUMANN W: FtsH - a single chain charonin? FEMS Microbiol. Rev. (1999) 23:1–11.
   Google Scholar
• MAKINO S, MAKINO T, ABE K et al.: Second transmem-brane segment of FtsH plays a role in its proteolytic activity and homo-oligomerization. FEBS Lett. (1999) 460:554–558.
   PubMed Web of Science ®Google Scholar
• ASAHARA Y, ATSUTA K, MOTOHASHI K, TAGUCHI H, YOHDA M, YOSHIDA M: FtsH recognizes proteins with unfolded structure and hydrolyzes the carboxyl side of hydrophobic residues. J. Biochem. (Tokyo) (2000) 127:931–937.
   PubMed Web of Science ®Google Scholar